TCI Wealth Advisors’s AnaptysBio ANAB Stock Holding History

TCI Wealth Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90	Closed	-$2K	–	2264
2022 Q1	$2K	Hold	90	–	–	﹤0.01%	1950
2021 Q4	$3K	Buy	90 +12	+15%	+$381	﹤0.01%	1978
2021 Q3	$2K	Hold	78	–	–	﹤0.01%	2092
2021 Q2	$2K	Buy	+78	New	+$1.87K	﹤0.01%	1942
2018 Q4	–	Sell	-1	Closed	–	–	1433
2018 Q3	$0	Sell	1 -1	-50%	-$83	﹤0.01%	1459
2018 Q2	$0	Buy	+2	New	+$168	﹤0.01%	1496

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCI Wealth Advisors's ANAB Position: Q2 2022 in Review

TCI Wealth Advisors sold out of AnaptysBio (ANAB) in Q2 2022, closing a stake of 90 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in ANAB in Q2 2018 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2022.

TCI Wealth Advisors reported no remaining AnaptysBio position as of Q2 2022 after selling out during the quarter.
TCI Wealth Advisors sold 90 AnaptysBio shares in Q2 2022, an estimated $2K.
TCI Wealth Advisors first reported a position in AnaptysBio in Q2 2018 and held it in 6 quarters.
TCI Wealth Advisors's AnaptysBio position peaked at $3K in Q4 2021.
124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.